Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Aleglitazar in drug-naïve type 2 diabetes mellitus
CTR20130320Phase 3Suspended
- Sponsor
- Roche
- Start
- Oct 2014
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of aleglitazar in type 2 diabetes mellitus (T2DM), sponsored by Roche. Started Oct 2014; status: suspended.
02
Drugs
aleglitazar
03
Conditions
type 2 diabetes mellitus (T2DM)
Beyond the preview
Go deeper on CTR20130320.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on CTR20130320.